Related Experiment Videos
[Beta-thalassemia: clinical manifestations]
1Service d'hématologie pédiatrique, Hôpital de La Timone, Marseille, France.
Bulletin De La Societe De Pathologie Exotique (1990)
|July 28, 2001
Summary
Beta-thalassemia, a genetic blood disorder, presents varied severity. Diagnosis involves Hb A2 levels, with severe forms requiring transfusions and iron chelation for survival.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Context:
- Beta-thalassemia is a monogenic disease with global distribution.
- Characterized by point mutations in the beta-globin gene.
- Clinical presentation ranges from asymptomatic trait to severe anemia.
Purpose:
- To outline the clinical spectrum and management of beta-thalassemia.
- To differentiate between thalassemia trait, major, and intermedia.
- To describe the characteristics of Hb S-beta-thalassemia.
Summary:
- Diagnosis of thalassemia trait relies on elevated Hb A2.
- Thalassemia major necessitates early, regular blood transfusions and iron chelation.
- Thalassemia intermedia affects approximately 10% of homozygous patients.
Impact:
- Effective management strategies, including iron chelation, prevent late mortality.
- Understanding disease heterogeneity aids in personalized patient care.
- Distinguishing Hb S-beta-thalassemia is crucial for predicting clinical course.